Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Investing Activities (2016 - 2025)

Nutex Health's Cash from Investing Activities history spans 16 years, with the latest figure at -$5.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 52.04% year-over-year to -$5.1 million; the TTM value through Dec 2025 reached -$5.2 million, up 6.49%, while the annual FY2025 figure was -$5.2 million, 6.49% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$5.1 million at Nutex Health, down from -$302000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $7.9 million in Q4 2022 and bottomed at -$25.6 million in Q2 2021.
  • The 5-year median for Cash from Investing Activities is -$2.2 million (2023), against an average of -$3.2 million.
  • The largest annual shift saw Cash from Investing Activities plummeted 963869.2% in 2021 before it skyrocketed 166.95% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$11.8 million in 2021, then surged by 166.95% to $7.9 million in 2022, then crashed by 89.02% to $865481.0 in 2023, then tumbled by 485.45% to -$3.3 million in 2024, then tumbled by 52.04% to -$5.1 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Cash from Investing Activities are -$5.1 million (Q4 2025), -$302000.0 (Q3 2025), and $196000.0 (Q2 2025).